123 related articles for article (PubMed ID: 34534789)
1. Role of SIX1, EYA2, and E-cadherin in ovarian carcinoma. Evidence on epithelial-mesenchymal transition from an immunohistochemical study.
Dawoud MM; Aiad HAES; Tawfiq EAE; Al-Qalashy FSA; Eissa N; El-Rebey HS
Ann Diagn Pathol; 2021 Dec; 55():151815. PubMed ID: 34534789
[TBL] [Abstract][Full Text] [Related]
2. Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties.
Farabaugh SM; Micalizzi DS; Jedlicka P; Zhao R; Ford HL
Oncogene; 2012 Feb; 31(5):552-62. PubMed ID: 21706047
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and Metastasis.
Zhou H; Blevins MA; Hsu JY; Kong D; Galbraith MD; Goodspeed A; Culp-Hill R; Oliphant MUJ; Ramirez D; Zhang L; Trinidad-Pineiro J; Mathews Griner L; King R; Barnaeva E; Hu X; Southall NT; Ferrer M; Gustafson DL; Regan DP; D'Alessandro A; Costello JC; Patnaik S; Marugan J; Zhao R; Ford HL
Cancer Res; 2020 Jun; 80(12):2689-2702. PubMed ID: 32341035
[TBL] [Abstract][Full Text] [Related]
4. The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors.
Bozhkova DM; Poryazova-Markova EG
Folia Med (Plovdiv); 2019 Jun; 61(2):296-302. PubMed ID: 31301662
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
[TBL] [Abstract][Full Text] [Related]
6. Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-β/Smad2/3 signaling pathway in papillary thyroid carcinoma.
Min WP; Wei XF
Auris Nasus Larynx; 2021 Jun; 48(3):487-495. PubMed ID: 33077306
[TBL] [Abstract][Full Text] [Related]
7. The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer.
Takai M; Terai Y; Kawaguchi H; Ashihara K; Fujiwara S; Tanaka T; Tsunetoh S; Tanaka Y; Sasaki H; Kanemura M; Tanabe A; Ohmichi M
J Ovarian Res; 2014 Jul; 7():76. PubMed ID: 25296567
[TBL] [Abstract][Full Text] [Related]
8. Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases.
Daraï E; Scoazec JY; Walker-Combrouze F; Mlika-Cabanne N; Feldmann G; Madelenat P; Potet F
Hum Pathol; 1997 Aug; 28(8):922-8. PubMed ID: 9269828
[TBL] [Abstract][Full Text] [Related]
9. Transcription coactivator Eya2 is a critical regulator of physiological hypertrophy.
Lee SH; Kim J; Ryu JY; Lee S; Yang DK; Jeong D; Kim J; Lee SH; Kim JM; Hajjar RJ; Park WJ
J Mol Cell Cardiol; 2012 Mar; 52(3):718-26. PubMed ID: 22197309
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma.
Du J; Sun B; Zhao X; Gu Q; Dong X; Mo J; Sun T; Wang J; Sun R; Liu Y
Gynecol Oncol; 2014 Jun; 133(3):575-83. PubMed ID: 24589413
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition markers in malignant ovarian germ cell tumors.
Solheim O; Førsund M; Tropé CG; Kraggerud SM; Nesland JM; Davidson B
APMIS; 2017 Sep; 125(9):781-786. PubMed ID: 28585395
[TBL] [Abstract][Full Text] [Related]
12. Eya2 overexpression promotes the invasion of human astrocytoma through the regulation of ERK/MMP9 signaling.
Wen Z; Liang C; Pan Q; Wang Y
Int J Mol Med; 2017 Nov; 40(5):1315-1322. PubMed ID: 28901379
[TBL] [Abstract][Full Text] [Related]
13. Expression and localization of e-cadherin in epithelial ovarian cancer.
Koensgen D; Freitag C; Klaman I; Dahl E; Mustea A; Chekerov R; Braicu I; Lichtenegger W; Sehouli J
Anticancer Res; 2010 Jul; 30(7):2525-30. PubMed ID: 20682978
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic significance of epithelial-mesenchymal transition-related markers and phenotype in serous ovarian cancer.
Song IH; Kim KR; Lim S; Kim SH; Sung CO
Pathol Res Pract; 2018 Oct; 214(10):1564-1571. PubMed ID: 30082157
[TBL] [Abstract][Full Text] [Related]
15. Structure-function analyses of the human SIX1-EYA2 complex reveal insights into metastasis and BOR syndrome.
Patrick AN; Cabrera JH; Smith AL; Chen XS; Ford HL; Zhao R
Nat Struct Mol Biol; 2013 Apr; 20(4):447-53. PubMed ID: 23435380
[TBL] [Abstract][Full Text] [Related]
16. VAV1 represses E-cadherin expression through the transactivation of Snail and Slug: a potential mechanism for aberrant epithelial to mesenchymal transition in human epithelial ovarian cancer.
Wakahashi S; Sudo T; Oka N; Ueno S; Yamaguchi S; Fujiwara K; Ohbayashi C; Nishimura R
Transl Res; 2013 Sep; 162(3):181-90. PubMed ID: 23856093
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of homeoproteins Six1 and Pax3 in breast phyllodes tumours correlates with histological grade and clinical outcome.
Tan WJ; Thike AA; Bay BH; Tan PH
Histopathology; 2014 May; 64(6):807-17. PubMed ID: 24438019
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility.
Stoyianni A; Goussia A; Pentheroudakis G; Siozopoulou V; Ioachim E; Krikelis D; Golfinopoulos V; Cervantes A; Bobos M; Fotsis T; Bellou S; Fountzilas G; Malamou-Mitsi V; Pavlidis N
Anticancer Res; 2012 Apr; 32(4):1273-81. PubMed ID: 22493359
[TBL] [Abstract][Full Text] [Related]
19. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
20. Cell adhesion molecule profiles, proliferation activity and p53 expression in advanced epithelial ovarian cancer induced malignant ascites-Correlation of tissue microarray and cytology microarray.
Toth L; Nagy B; Mehes G; Laszlo E; Molnar PP; Poka R; Hernadi Z
Pathol Res Pract; 2018 Jul; 214(7):978-985. PubMed ID: 29801775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
